Callahan B C, Lisecki E J, Banks R E, Dalton J E, Cook S D, Wolff J D
Department of Surgery, Fitzsimons Army Medical Center, Aurora, Colorado 80045-5001.
J Bone Joint Surg Am. 1995 Feb;77(2):225-30. doi: 10.2106/00004623-199502000-00008.
The attachment of bone to hydroxyapatite-coated and uncoated porous implants made of cobalt-chromium-molybdenum alloy was investigated with and without postoperative administration of warfarin sodium. The implants were placed transcortically in the femoral diaphysis of adult female goats and were evaluated after three, six, and twelve weeks in situ. Mechanical push-out testing and histological evaluation revealed that the attachment strength and the ingrowth of bone at the bone-implant interface increased with time in situ for both the hydroxyapatite-coated and the uncoated implants. The administration of warfarin significantly impaired both the attachment strength and the ingrowth of bone at twelve weeks. At twelve weeks, the attachment strength and bone ingrowth of the hydroxyapatite-coated implants in the animals that had received warfarin were statistically equal to those of the uncoated implants in the control animals.
研究了钴铬钼合金制成的羟基磷灰石涂层和未涂层多孔植入物在术后给予和不给予华法林钠的情况下与骨的附着情况。将植入物经皮质放置在成年雌性山羊的股骨干中,并在原位放置3周、6周和12周后进行评估。机械推出试验和组织学评估表明,对于羟基磷灰石涂层和未涂层的植入物,骨-植入物界面处的附着强度和骨向内生长均随原位时间增加。华法林的给药在12周时显著损害了附着强度和骨向内生长。在12周时,接受华法林的动物中羟基磷灰石涂层植入物的附着强度和骨向内生长在统计学上与对照动物中未涂层植入物的相等。